Nu-Med Plus (NUMD) Non-Current Debt (2017 - 2021)

Nu-Med Plus (NUMD) posted Non-Current Debt of $9384.0 for Q1 2021, little changed sequentially from $9384.0 in Q4 2020.

Nu-Med Plus (NUMD) Non-Current Debt (2017 - 2021) Analysis & Trends

Nu-Med Plus has reported Non-Current Debt for 5 years, with the latest figure at $9384.0 in Q1 2021.

Quarterly Non-Current Debt changed N/A year-over-year to $9384.0 in Q1 2021, while the trailing twelve-month figure through Mar 2021 was $9384.0 (changed N/A YoY) and the FY2020 annual result came in at $9384.0, changed N/A from the prior year.
Non-Current Debt was little changed at $9384.0 in Q1 2021 per NUMD's latest filing, from $9384.0 in the prior quarter.
Over five years, Non-Current Debt peaked at $14453.0 in Q2 2017 and troughed at $2944.0 in Q3 2019.
A 5-year average of $8709.0 and a median of $9384.0 in 2020 frame the typical range for Non-Current Debt.
The sharpest annual moves came in 2018 and 2020: Non-Current Debt plunged 68.31% in 2018, then soared 218.75% in 2020.
Over 5 years, Non-Current Debt stood at $10567.0 in 2017, then rose by 3.71% to $10959.0 in 2018, then tumbled by 73.14% to $2944.0 in 2019, then jumped by 218.75% to $9384.0 in 2020, then changed by 0.0% to $9384.0 in 2021.
According to Business Quant data, Non-Current Debt over the past three periods registered $9384.0, $9384.0, and $9384.0 for Q1 2021, Q4 2020, and Q3 2020 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Non-Current Debt (Qtr)
1	Abbott Laboratories	199.20 Bn	193.60 Bn	7.27 Bn	29.60 Bn
2	Stryker	127.66 Bn	124.19 Bn	4.50 Bn	14.19 Bn
3	Medtronic	118.98 Bn	109.76 Bn	6.41 Bn	26.17 Bn
4	Boston Scientific	73.25 Bn	72.71 Bn	3.85 Bn	10.92 Bn
5	Edwards Lifesciences	51.93 Bn	47.68 Bn	1.35 Bn	598.70 Mn
6	Dexcom	34.37 Bn	32.42 Bn	830.00 Mn	-
7	GE HealthCare Technologies	33.89 Bn	31.78 Bn	2.18 Bn	10.09 Bn
8	Koninklijke Philips	26.36 Bn	23.04 Bn	4.55 Bn	7.34 Bn
9	Steris	23.03 Bn	22.55 Bn	684.20 Mn	1.65 Bn
10	Nu-Med Plus	2.03 Mn	2.02 Mn	-	-

Download Data